Literature DB >> 21119707

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.

Nancy Hamel1, Bing-Jian Feng, Lenka Foretova, Dominique Stoppa-Lyonnet, Steven A Narod, Evgeny Imyanitov, Olga Sinilnikova, Laima Tihomirova, Jan Lubinski, Jacek Gronwald, Bohdan Gorski, Thomas v O Hansen, Finn C Nielsen, Mads Thomassen, Drakoulis Yannoukakos, Irene Konstantopoulou, Vladimir Zajac, Sona Ciernikova, Fergus J Couch, Celia M T Greenwood, David E Goldgar, William D Foulkes.   

Abstract

The BRCA1 mutation c.5266dupC was originally described as a founder mutation in the Ashkenazi Jewish (AJ) population. However, this mutation is also present at appreciable frequency in several European countries, which raises intriguing questions about the origins of the mutation. We genotyped 245 carrier families from 14 different population groups (Russian, Latvian, Ukrainian, Czech, Slovak, Polish, Danish, Dutch, French, German, Italian, Greek, Brazilian and AJ) for seven microsatellite markers and confirmed that all mutation carriers share a common haplotype from a single founder individual. Using a maximum likelihood method that allows for both recombination and mutational events of marker loci, we estimated that the mutation arose some 1800 years ago in either Scandinavia or what is now northern Russia and subsequently spread to the various populations we genotyped during the following centuries, including the AJ population. Age estimates and the molecular evolution profile of the most common linked haplotype in the carrier populations studied further suggest that c.5266dupC likely entered the AJ gene pool in Poland approximately 400-500 years ago. Our results illustrate that (1) BRCA1 c.5266dupC originated from a single common ancestor and was a common European mutation long before becoming an AJ founder mutation and (2) the mutation is likely present in many additional European countries where genetic screening of BRCA1 may not yet be common practice.
© 2011 Macmillan Publishers Limited All rights reserved 1018-4813/11

Entities:  

Mesh:

Year:  2010        PMID: 21119707      PMCID: PMC3062007          DOI: 10.1038/ejhg.2010.203

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  31 in total

1.  Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins.

Authors:  N Ah Mew; N Hamel; M Galvez; M Al-Saffar; W D Foulkes
Journal:  Clin Genet       Date:  2002-08       Impact factor: 4.438

2.  Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.

Authors:  Ramūnas Janavicius; Ingrida Pepalyte; Vaidutis Kucinskas
Journal:  Breast Cancer Res Treat       Date:  2008-09-02       Impact factor: 4.872

3.  Mutation of human short tandem repeats.

Authors:  J L Weber; C Wong
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

4.  Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.

Authors:  A Kataki; Ip Gomatos; N Pararas; A Armakolas; D Panousopoulos; G Karantzikos; D Voros; G Zografos; C Markopoulos; E Leandros; Mm Konstadoulakis
Journal:  Clin Genet       Date:  2005-04       Impact factor: 4.438

5.  Breast cancer predisposing alleles in Poland.

Authors:  B Górski; C Cybulski; T Huzarski; T Byrski; J Gronwald; A Jakubowska; M Stawicka; S Gozdecka-Grodecka; M Szwiec; K Urbański; J Mituś; E Marczyk; J Dziuba; P Wandzel; D Surdyka; O Haus; H Janiszewska; T Debniak; A Tołoczko-Grabarek; K Medrek; B Masojć; M Mierzejewski; E Kowalska; S A Narod; J Lubiński
Journal:  Breast Cancer Res Treat       Date:  2005-07       Impact factor: 4.872

6.  Mutational analysis of the BRCA1 gene in 30 Czech ovarian cancer patients.

Authors:  M Zikan; P Pohlreich; J Stribrna
Journal:  J Genet       Date:  2005-04       Impact factor: 1.166

7.  How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.

Authors:  Celia M T Greenwood; Shuying Sun; Justin Veenstra; Nancy Hamel; Bethany Niell; Stephen Gruber; William D Foulkes
Journal:  BMC Genet       Date:  2010-05-14       Impact factor: 2.797

8.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

9.  One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.

Authors:  S Malander; M Ridderheim; A Måsbäck; N Loman; U Kristoffersson; H Olsson; M Nilbert; A Borg
Journal:  Eur J Cancer       Date:  2004-02       Impact factor: 9.162

10.  BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.

Authors:  Marie Soegaard; Susanne Kruger Kjaer; Mark Cox; Eva Wozniak; Estrid Høgdall; Claus Høgdall; Jan Blaakaer; Ian J Jacobs; Simon A Gayther; Susan J Ramus
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

View more
  39 in total

1.  Earlier age of onset in BRCA carriers-anticipation or cohort effect?: A Countercurrents Series.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.

Authors:  Yael Laitman; Bing-Jian Feng; Itay M Zamir; Jeffrey N Weitzel; Paul Duncan; Danielle Port; Eswary Thirthagiri; Soo-Hwang Teo; Gareth Evans; Ayse Latif; William G Newman; Ruth Gershoni-Baruch; Jamal Zidan; Shani Shimon-Paluch; David Goldgar; Eitan Friedman
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

3.  Ancestry, Temporality, and Potentiality: Engaging Cancer Genetics in Southern Brazil.

Authors:  Sahra Gibbon
Journal:  Curr Anthropol       Date:  2013-10

Review 4.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

5.  Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

Authors:  Brian S Finkelman; Wendy S Rubinstein; Sue Friedman; Tara M Friebel; Shera Dubitsky; Niecee Singer Schonberger; Rochelle Shoretz; Christian F Singer; Joanne L Blum; Nadine Tung; Olufunmilayo I Olopade; Jeffrey N Weitzel; Henry T Lynch; Carrie Snyder; Judy E Garber; Joellen Schildkraut; Mary B Daly; Claudine Isaacs; Gabrielle Pichert; Susan L Neuhausen; Fergus J Couch; Laura van't Veer; Rosalind Eeles; Elizabeth Bancroft; D Gareth Evans; Patricia A Ganz; Gail E Tomlinson; Steven A Narod; Ellen Matloff; Susan Domchek; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

6.  Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.

Authors:  I Gorodetska; S Serga; T Lahuta; L Ostapchenko; S Demydov; N Khranovska; O Skachkova; M Inomistova; O Kolesnik; V Svintsitsky; N Tsip; A Peresunko; N Kmit'; O Manzhura; Z Rossokha; O Popova; H Salomakhina; S Kyriachenko; I Kozeretska
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

7.  Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Authors:  Gabriela Torres-Mejía; Robert Royer; Marcia Llacuachaqui; Mohammad R Akbari; Anna R Giuliano; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Elad Ziv; Eduardo Lazcano-Ponce; Catherine M Phelan; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

8.  Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.

Authors:  Vladimir M Moiseyenko; Nikita M Volkov; Evgeny N Suspistin; Grigoriy A Yanus; Aglaya G Iyevleva; Ekatherina Sh Kuligina; Alexandr V Togo; Alexandr V Kornilov; Alexandr O Ivantsov; Evgeny N Imyanitov
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

9.  Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.

Authors:  Chloé Tessereau; Yann Lesecque; Nastasia Monnet; Monique Buisson; Laure Barjhoux; Mélanie Léoné; Bingjian Feng; David E Goldgar; Olga M Sinilnikova; Sylvain Mousset; Laurent Duret; Sylvie Mazoyer
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

10.  Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.

Authors:  Julie L Boyle; Andrew W Hahn; Ashley L Kapron; Wendy Kohlmann; Samantha E Greenberg; Timothy J Parnell; Craig C Teerlink; Benjamin L Maughan; Bing-Jian Feng; Lisa Cannon-Albright; Neeraj Agarwal; Kathleen A Cooney
Journal:  JCO Precis Oncol       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.